Cornea

Erin Rueff, OD, PhD, FAAO, details the presentation she gave at this year's conference on the importance of validating patients' symptoms in cases of neuropathic corneal pain.

According to the company, the topography module now makes the OCT the only one with FDA cleared OCT-A metrics on the market.

An overview of a case of SLK treated with complete ocular lavage facilitated by an irrigating eyelid retractor.

Young will be aiding in expanding real-world evidence programs to promotion the adoption of Brightstar’s BrightMEM corneal allograft for the treatment of limbal stem cell deficiency and persistent epithelial defects.

According to the UK study, for every 0.5-diopter increase in mean spherical equivalent, a 6% higher risk was attributed in developing depressive disorders.

Smart contact lenses can be used to correct vision, monitor the health of the user, and flag and treat diseases for patients diagnosed with chronic health conditions such as glaucoma and diabetes.

Investigators conducted a cross-sectional study from December 2016 to March 2024 in patients with acute infectious conjunctivitis.

Study investigators found that the injuries ranged from deep thermal burns to full-thickness corneal or scleral lacerations, with one case of traumatic cataract.

Specular microscopy showed that the ocular symptoms in the patients who had had COVID-19 included conjunctival hyperemia, foreign body sensation, tearing, ocular secretion, and chemosis.

Kefla G. Brown, OD, MS, overviewed her NOA Convention talk on identifying both common and uncommon etiologies of pediatric uveitis.

Study investigators conducted a case-control study to investigate the corneal topography parameters and biomechanics in patients with alopecia areata.

The primary endpoint will be pain improvement as measured by visual analogue scale (VAS) compared to placebo.

What to know about evolving guidelines and potential medicolegal risks.

As part of the sports and performance vision section of the AOA, Vittorio Mena, OD, MS, shares information on how to bolster athletes' performance through enhanced vision care.

The study also discovered a need for more blatant labeling on e-liquid containers to help reduce accidental contact with the ocular surface.

The company plans to finalize its Phase 3 development plans following an End-of-Phase 2 meeting with the FDA.

The study demonstrated sustained safety and efficacy of cyclosporine ophthalmic solution (Vevye) 0.1%, with many patients now entering their sixth refill cycle, according to the company.

The pachymeter is the most lightweight handheld product of its kind on the market, according to the company.

Investigators found more cases than expected following tomography of 2007 eyes.

Alan Glazier, OD, FAAO, talked about moderating a session discussing the education of the public on keratoconus, from screening to diagnosis, and the roles clinicians can take to assist in the patients' anxieties.

Andrew Morgenstern, OD, FAAO, FNAP, President and Co-founder of IKA, talked about his session at the meeting that discussed the prevalence of keratoconus in the pediatric population in the US.

The 2 FDA registration trials for perfluorohexyloctane resulted in scientifically significant results for improvement of mild and moderate symptoms of dry eye disease.

The collective enhances education, research, and quality of life.